Table 1.
Demographic and immunopathologic characteristics of the patients of the GEMRITUX cohort, according to therapeutic intervention at M0, M3, and M6
Characteristics | Whole Cohort, n=58 | NIAT, n=29 | RITUX, n=29 | P Value |
---|---|---|---|---|
Age | 56.5 [42.0–63.0] | 59.0 [44.0–63.0] | 52.0 [41.0–63.0] | 0.5 |
Sex | 0.4 | |||
Men | 42 (72.4) | 19 | 23 | |
Women | 16 (27.6) | 10 | 6 | |
Proteinuria at M0, g/g of serum creatinine | 8.2 [4.8–10.0] | 7.4 [6.2–9.0] | 8.4 [4.4–11.0] | 0.51 |
Serum albumin at M0, g/dl | 2.2 [1.9–2.5] | 2.2 [2.0–2.5] | 2.2 [1.8–2.5] | 0.52 |
Serum creatinine at M0, mg/L | 10.8 [9.0–13.8] | 10.4 [8.7–13.8] | 11.5 [9.4–13.1] | 0.48 |
PLA2R1-Ab at M0, RU/ml | 101.5 [31.2–481.2] | 199.5 [24.2–480.0] | 100.5 [35.4–481.2] | 0.85 |
CysR at M0, RU/ml | 1423.5 [369.0–3240.0] | 1572.0 [494.0–3240.0] | 1256.0 [270.0–3114.0] | 0.52 |
CTLD1 at M0, RU/ml | 157.0 [0.0–2334.0] | 12.0 [0.0–1190.0] | 471.0 [0.0–2334.0] | 0.33 |
CTLD7 at M0, RU/ml | 220.5 [23.0–609.0] | 136.0 [36.0–662.0] | 223.0 [13.0–604.0] | 0.65 |
Group M0 | 0.74 | |||
CysR | 20 (34.48) | 11 (37.93) | 9 (31.03) | |
CysRC1 | 8 (13.79) | 4 (13.79) | 4 (13.79) | |
CysRC7 | 10 (17.24) | 6 (20.69) | 4 (13.79) | |
CysRC1C7 | 20 (34.48) | 8 (27.59) | 12 (41.38) | |
Spreading M0 | 38/58 (65.6) | 18 (62.1) | 20 (68.9) | 0.78 |
Proteinuria at M3, g/g of serum creatininea | 5.1 [3.2–7.6] | 5.0 [3.0–8.5] | 5.1 [3.5–7.4] | 0.86 |
Serum albumin at M3, g/dlb | 2.6 [2.0–2.9] | 2.3 [1.8–2.7] | 2.7 [2.1–3.1] | 0.12 |
Serum creatinine at M3, mg/La | 11.5 [9.4–13.6] | 11.5 [9.7–13.9] | 11.8 [9.0–13.6] | 0.99 |
PLA2R1-Ab at M3, RU/mlc | 43.1 [0–102.5] | 70.5 [30.3–325.9] | 0.0 [0.0–60.5] | 0.002 |
Group M3d | 0.002 | |||
Negative | 12 (24.5) | 0 (0.0) | 12 (46.2) | |
CysR | 10 (20.4) | 7 (30.4) | 3 (11.5) | |
CysRC1 | 9 (18.4) | 6 (26.1) | 3 (11.5) | |
CysRC7 | 6 (12.2) | 3 (13.1) | 3 (11.5) | |
CysRC1C7 | 12 (24.5) | 7 (30.4) | 5 (19.2) | |
Spreading M3d | 27/49 (55.1) | 16 (69.6) | 11 (42.3) | 0.09 |
Proteinuria at M6, g/g of serum creatininee | 4.4 [2.0–7.3] | 6.2 [2.2–7.5] | 3.7 [1.8–6.5] | 0.21 |
Serum albumin at M6, g/dle | 2.6 [2.1–3.3] | 2.4 [2.0–2.9] | 2.9 [2.5–3.4] | 0.07 |
Serum creatinine at M6, mg/Le | 11.9 [9.4–14.8] | 12.0 [9.4–14.4] | 11.9 [9.8–14.8] | 0.71 |
PLA2R1-Ab at M6, RU/mlf | 30.1 [0–98.5] | 57.2 [16.5–298.0] | 0 [0–57.0] | 0.01 |
Group M6c | ||||
Negative | 17 (34.0) | 0 (0.0) | 17 (65.4) | |
CysR | 14 (28.0) | 12 (50.0) | 2 (7.7) | <0.001 |
CysRC1 | 5(10.0) | 4 (16.7) | 1 (3.9) | |
CysRC7 | 2 (4.0) | 2 (8.3) | 0 (0.0) | |
CysRC1C7 | 12 (24.0) | 6 (25.0) | 6 (23.1) | |
Spreading M6c | 19/50 (38.0) | 12/24 (50.0) | 7/26 (26.9) | 0.15 |
Data are shown as n (%) or median [interquartile range].
One missing value.
Two missing values.
Eight missing values.
Nine missing values.
Four missing values.
Five missing values.